Biopharma

관련학술자료

Clinical Immune Monitoring and Biomarker Data of TAVO Monotherapy Compared to TAVO with Pembrolizumab in Metastatic Melanoma Supports the Rationale for Combination Therapy

운영자 2018.09.10

첨부파일 | Algazi-SMR-10-19-17-FINAL.pdf 다운로드

Clinical Immune Monitoring and Biomarker Data of TAVO Monotherapy Compared to TAVO with Pembrolizumab in Metastatic Melanoma Supports the Rationale for Combination Therapy

9th Annual World Congress of Melanoma – A Joint Meeting with the Society of Melanoma Research